Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 8/20 | 0.53 |
| ▸ | CALCR | P30988 | 8/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 7/20 | 0.50 |
| ▸ | PLG | P00747 | 2/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.49 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | KDM5A | P29375 | 1/20 | 0.47 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.47 |
| ▸ | GLP1R | P43220 | 1/20 | 0.47 |
| ▸ | GIPR | P48546 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22550646 | 0.83 | RAMP3 (0.53) | RAMP3CALCRCXCR4KDM1AMAOB | |
| SCHEMBL22423719 | 0.82 | RAMP3 (0.56) | RAMP3CALCRKDM1AMAOBKDM5A | |
| SCHEMBL22550672 | 0.82 | GLP1R (0.54) | RAMP3CALCRPLGPRSS1PRSS2 | |
| SCHEMBL22550645 | 0.81 | PLG (0.57) | PLGPRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL6176082 | 0.79 | RAMP3 (0.54) | RAMP3CALCR | |
| SCHEMBL6176075 | 0.79 | RAMP3 (0.52) | RAMP3CALCR | |
| SCHEMBL29664131 | 0.79 | RAMP3 (0.52) | RAMP3CALCR | |
| SCHEMBL12428852 | 0.78 | RAMP3 (0.57) | RAMP3CALCRCXCR4 | |
| SCHEMBL7113668 | 0.76 | FOLH1 (0.50) | RAMP3CALCRPLGPRSS1PRSS2 | |
| SCHEMBL26209751 | 0.75 | PLG (0.53) | RAMP3CALCRCXCR4PLGPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200323973-A1 | EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS | INSTITUTE FOR SYSTEMS BIOLOGY | 2020-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323973-A1 | EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS | MICA, ICOS, CD47 | RAMP3 3123/4885CALCR 1922/4885CXCR4 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.